A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Awasthi, Sanjay, M.D. Bookmark and Share

Sanjay Awasthi, M.D. Research

My research interests are focused on deciphering the role of redox-metabolism in disease and aging, and mechanisms through which antioxidants function.  I have purified and studied cytosolic and membrane enzymes of redox-metabolism linked to diseases of brain, blood, cancer, inflammation, vision, digestion, circulation, endocrine hormones, and immune system over the past three decades, last two as an independent investigator. My recent focus has been on deciphering the interactions between mercapturic acid pathway, kinase signaling cascades, ubiquitination, and DNA methylation.  My clinical goals remain the translation of basic science to clinical applications to alleviate human suffering.

Sanjay Awasthi, M.D., Lab Members

Sanjay Awasthi, M.D.
Professor
626-256-HOPE (4673) ext.  31118
 
Jyotsana Singhal
Staff Scientist
626-256-HOPE (4673) ext.  60651
 
Sharad Singhal, Ph.D.
Research Professor
626-256-HOPE (4673) ext.  31238
 
Sushma Yadav, Ph.D.
Assistant Research Professor
626-256-HOPE (4673) ext.  61544
 

Awasthi, Sanjay, M.D.

Sanjay Awasthi, M.D. Research

My research interests are focused on deciphering the role of redox-metabolism in disease and aging, and mechanisms through which antioxidants function.  I have purified and studied cytosolic and membrane enzymes of redox-metabolism linked to diseases of brain, blood, cancer, inflammation, vision, digestion, circulation, endocrine hormones, and immune system over the past three decades, last two as an independent investigator. My recent focus has been on deciphering the interactions between mercapturic acid pathway, kinase signaling cascades, ubiquitination, and DNA methylation.  My clinical goals remain the translation of basic science to clinical applications to alleviate human suffering.

Lab Members

Sanjay Awasthi, M.D., Lab Members

Sanjay Awasthi, M.D.
Professor
626-256-HOPE (4673) ext.  31118
 
Jyotsana Singhal
Staff Scientist
626-256-HOPE (4673) ext.  60651
 
Sharad Singhal, Ph.D.
Research Professor
626-256-HOPE (4673) ext.  31238
 
Sushma Yadav, Ph.D.
Assistant Research Professor
626-256-HOPE (4673) ext.  61544
 
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.
 

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
 
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
 
 
 
 


NEWS & UPDATES
  • When Keith McKinny, 29, was first diagnosed with lymphoma and leukemia in 2010, the first person he thought of was former boyfriend Jason Mullins. The two hadn’t been in contact with each other for some time, but McKinny couldn’t think of anyone else with whom he wanted to be during that difficult period....
  • Yesenia Portillo’s search for a bone marrow donor started close to home. Her brother, sister and seven cousins all underwent testing, but none of them were a close enough match to donate the bone marrow stem cells she desperately needed for her transplant. Yesenia, now 16, had always been healthy and active. Bu...
  • Some of City of Hope’s most high-impact achievements have arisen from City of Hope’s globally recognized bone marrow transplant (BMT) program. The annual Karl G. Blume – Gerhard Schmidt Memorial Lecture in Transplantation Biology & Medicine — commemorating two of the most influential and revered...
  • Guido Marcucci, M.D., wants to put himself out of business. A respected clinician and esteemed basic and translational scientist, Marcucci joins City of Hope as co-director of the Gehr Family Center for Leukemia Research within the Hematologic Malignancies and Stem Cell Transplantation Institute. In this positi...
  • To say that myelofibrosis patients need more treatment options would be an understatement. The severely low platelet counts, known as thrombocytopenia, that are one of the hallmark symptoms of the disease can lead to chronic fatigue and weakness that not only damage quality of life but, ultimately, shorten life...
  • Patients with metastatic colorectal cancer often stop responding to the primary drugs used against the disease, leaving them with few options and little hope. Determined to increase those options, doctors and researchers at City of Hope are conducting two clinical trials that could lead to new treatments for pe...
  • Investigators working at City of Hope are making many significant inroads against many forms of cancer. To do that, they have to take a variety of approaches. Molecular oncology researchers focus on abnormal cancer-associated activity in a cell’s nucleus. One especially prominent factor in many breast and ovari...
  • In light of the new breast cancer screening guidelines, which call for women to have mammograms every other year from age 50 to 74, it’s more important than ever for women to understand their individual risk. On Monday, the U.S. Preventive Services Task force released new breast cancer screening guideline...
  • Cancer patients need, and deserve, more than medical care. They and their families need high-quality supportive care – that is, care that addresses their physical, emotional and spiritual well-being. Health care professionals increasingly understand this, but starting such programs from scratch isn’t easy...
  • Each year, City of Hope patients given another chance at life gather to pose for a picture like this one. Going on its 39th year, the celebration of patients free of blood cancers thanks to bone marrow or stem cell transplants has grown such that a photographer has to scale a cherry picker just to […]
  • Cancer patients who are participating in early-stage clinical trials need extra emotional and physical support due to their additional stress and often unique symptoms. Now an effort by researchers at City of Hope to create a model for such support has received a $6.8 million grant from the National Cancer Inst...
  • The need for improvements in treating malignant brain tumors has never been greater. Survival for many patients with these tumors are sometimes measured in just months. One reason that therapeutic options are limited is that traditional surgery is deemed too risky for many brain tumors, especially for those in ...
  • “Honestly, there’s nothing special about my story,” protested Daniel Samson, as he bounced Layla, his 3 1/2-year-old daughter, on his lap and put on a video for her to watch. “I just want to tell it for my own sake, and share it with other men who may be going through this chaos.” Samson spoke […]
  • As far back as he can remember, Jonathan Yamzon, M.D., wanted to be a doctor. “I knew it from the get-go,” he said, matter-of-factly. “I always envisioned it as the ideal; the supreme thing one could do with one’s life.” The youngest of six children, Yamzon was barely a toddler when his family moved to [&...
  • There’s never a “good” time for cancer to strike. With testicular cancer, the timing can seem particularly unfair. This disease targets young adults in the prime of life; otherwise healthy people unaccustomed to any serious illness, let alone cancer. And suddenly … “I can only imagine what they must...